Parecoxib — CAS 198470-85-8

Parecoxib is a prodrug of valdecoxib, a highly selective cyclooxygenase-2 (COX-2) inhibitor used for the short-term treatment of acute postoperative pain. It is the only parenteral COX-2 inhibitor available. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Short-term treatment of acute postoperative pain
• Perioperative analgesia as an alternative to opioids
• Management of pain after orthopedic, abdominal, and gynecological surgery
• Reduction of opioid requirements in multimodal analgesia protocols

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support